Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience

The aim of this study was to assess the efficacy of PRRT in patients with advanced neuroendocrine tumors (NETs). Patients and Methods. From January 2007 to August 2011, we enrolled 65 patients (m/f 38/27; mean age 65 years, range 33–83) with advanced NETs having enhanced SSTR expression, treated wit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Filice, A., Fraternali, A., Frasoldati, A., Asti, M., Grassi, E., Massi, L., Sollini, M., Froio, A., Erba, P. A., Versari, A.
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3425839/
https://ncbi.nlm.nih.gov/pubmed/22934111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/320198
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares